Li Yuhua, Liu Xiguang, Zhang Hongjun, Jiang Tao, Xiao Wenjing, Zhao Shufen, Yu Xiaoyun, Han Fanjie
Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.
Oncol Lett. 2016 Dec;12(6):4319-4326. doi: 10.3892/ol.2016.5278. Epub 2016 Oct 18.
The present study identified that fibroblast growth factor receptor 3 (FGFR3) was significantly upregulated in bone metastasis of lung adenocarcinoma. RNA interference (RNAi) is a powerful approach for treating a wide range of human diseases, including cancer, through downregulating the expression of selected genes. In the present study, the invasiveness of A549 cells cultured was altered by small interfering (si)RNA targeting FGFR3, and the regulatory effect of silencing FGFR3 on the expression levels of E-cadherin and matrix metalloproteinase (MMP)9 was investigated. Human lung adenocarcinoma A549 cells were transfected with synthetic specific siRNAs targeting a fragment of the FGFR3 gene (namely, siRNA-855, siRNA-1447 and siRNA-2076) or with negative control (NC) siRNA. Cells were divided into five groups (A, siRNA-855 group; B, siRNA-1447 group; C, siRNA-2076 group; D, NC-siRNA group; and E, blank control group). The effect of the above siRNAs targeting FGFR3 on the invasion capacity of A549 cells was detected by Transwell assay. siRNAs against FGFR3 were transfected into A549 cells with by Lipofectamine 2000, and the expression levels of FGFR3, E-cadherin and MMP9 were measured by reverse transcription-quantitative polymerase chain reaction and western blot assay. The experimental findings indicated that the expression levels of FGFR3 and MMP9 were significantly reduced in the siRNA-FGFR3-transfected groups (A-C groups), compared with those in the D and E groups (P<0.01). In addition, the expression levels of E-cadherin were markedly elevated in the A-C groups, compared with those in the D and E groups (P<0.01). There was no significant difference in E-cadherin expression between the A-C groups, or between the D and E groups (P>0.05). These results indicated that siRNA-FGFR3 was able to decrease the invasiveness of A549 cells, inhibit the expression of MMP9 and increase the expression of E-cadherin by downregulating the expression of FGFR3. Taken together, the results of the present study indicated that the upregulation of E-cadherin expression and the downregulation of MMP9 expression are able to inhibit the migration of A549 cells, and siRNA silencing FGFR3 acts as a tumor suppressor in these cells.
本研究发现,成纤维细胞生长因子受体3(FGFR3)在肺腺癌骨转移中显著上调。RNA干扰(RNAi)是一种通过下调特定基因表达来治疗包括癌症在内的多种人类疾病的有效方法。在本研究中,靶向FGFR3的小干扰(si)RNA改变了培养的A549细胞的侵袭性,并研究了沉默FGFR3对E-钙黏蛋白和基质金属蛋白酶(MMP)9表达水平的调节作用。用靶向FGFR3基因片段的合成特异性siRNAs(即siRNA-855、siRNA-1447和siRNA-2076)或阴性对照(NC)siRNA转染人肺腺癌A549细胞。细胞分为五组(A,siRNA-855组;B,siRNA-1447组;C,siRNA-2076组;D,NC-siRNA组;E,空白对照组)。通过Transwell实验检测上述靶向FGFR3的siRNAs对A549细胞侵袭能力的影响。用Lipofectamine 2000将针对FGFR3的siRNAs转染到A549细胞中,通过逆转录-定量聚合酶链反应和蛋白质免疫印迹法检测FGFR3、E-钙黏蛋白和MMP9的表达水平。实验结果表明,与D组和E组相比,转染siRNA-FGFR3的组(A-C组)中FGFR3和MMP9的表达水平显著降低(P<0.01)。此外,与D组和E组相比,A-C组中E-钙黏蛋白的表达水平显著升高(P<0.01)。A-C组之间或D组和E组之间E-钙黏蛋白表达无显著差异(P>0.05)。这些结果表明,siRNA-FGFR3能够通过下调FGFR3的表达来降低A549细胞的侵袭性,抑制MMP9的表达并增加E-钙黏蛋白的表达。综上所述,本研究结果表明,E-钙黏蛋白表达上调和MMP9表达下调能够抑制A549细胞的迁移,并且siRNA沉默FGFR3在这些细胞中起到肿瘤抑制作用。